GlassScriptPhysician profile
Sandeep Kancharla
NPI 1417419995
$4,165.59
in general payments reported to CMS, 2019-2025
29 companies · $1,217 in 2025
The $1,217 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.71 · 2021: $355 · 2022: $1,065 · 2023: $829 · 2024: $686 · 2025: $1,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,730.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $743.79 | 2023-2025 | Impella |
| Janssen Pharmaceuticals, INC | $577.99 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $398.44 | 2021-2025 | Wainua, Farxiga, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $395.82 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $219.36 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $200.56 | 2023-2025 | Camzyos, Eliquis |
| Pfizer INC. | $200.00 | 2022-2025 | |
| Boston Scientific Corporation | $175.37 | 2022-2025 | General - Vascular Access, Latitude Communicator Power Supply, Lux-Dx Insertable Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $155.65 | 2022-2023 | |
| Irhythm Technologies, INC. | $146.73 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Actelion Pharmaceuticals US, INC. | $107.54 | 2022-2024 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $104.72 | 2022-2025 | Verquvo, Winrevair |
| Impulse Dynamics (USA) INC. | $103.62 | 2022-2023 | Optimizer |
| Abbott Laboratories | $94.91 | 2024-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procyrion, INC. | $75.10 | 2024-2025 | Aortix System |
| Novo Nordisk INC | $55.09 | 2022-2025 | Wegovy |
| United Therapeutics Corporation | $34.87 | 2025 | Tyvaso |
| Scpharmaceuticals INC. | $32.47 | 2024-2025 | |
| Chiesi USA, INC. | $30.02 | 2023-2024 | Kengreal, Cleviprex, Juxtapid |
| Alnylam Pharmaceuticals INC. | $27.38 | 2025 | Amvuttra |
| Philips North America LLC | $25.03 | 2022 | |
| Bridgebio Pharma, INC. | $20.07 | 2025 | Attruby |
| Livanova USA, INC. | $18.50 | 2022 | |
| Medtronic, INC. | $18.09 | 2023 | Cobalt Dr Mri Surescan |
| Teleflex LLC | $16.74 | 2025 | Trapliner |
| Kiniksa Pharmaceuticals International, Plc | $16.67 | 2024 | Arcalyst |
| Takeda Pharmaceuticals U.S.A., INC. | $14.71 | 2020 | |
| Biotronik INC. | $13.35 | 2023 | Renamic Neo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Kancharla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.